Freshpet, Inc. (FRPT - Free Report) — a renowned pet food products company — is likely to register top-line growth when it reports second-quarter 2021 results on Aug 2, after market close. The Zacks Consensus Estimate for revenues is pegged at $105.2 million, which indicates growth of 31.5% from the prior-year quarter’s reported figure.
The Zacks Consensus Estimate for second-quarter bottom line currently stands at a loss of 6 cents per share. The company incurred break-even earnings in the year-ago quarter. The consensus mark has remained stable in the past 30 days. The company incurred a loss in the past two quarters.
Key Aspects to Note
Freshpet’s top line during the second quarter is likely to have gained from strong product offerings backed by the company’s prudent innovation efforts. It has been ramping up distribution and trade inventory to cater to consumers’ needs for fresh and natural ingredients based pet food products. The company is gaining from improved shipments, consumption trends, retail availability and overall production levels.
Freshpet’s pet specialty channel is likely to have performed well in the second quarter, driven by expanded fridges across stores. These factors apart, the company’s sturdy e-commerce business and prudent efforts to boost international business are likely to have been upsides.
The company may have incurred higher fright costs in the to-be-reported quarter. Higher freight costs are a result of lower fill rates. Inflationary trends in beef and labor costs as well as higher production expenses are also likely to have dented the company’s bottom line.
What the Zacks Model Unveils
Our proven model does not conclusively predict an earnings beat for Freshpet this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Freshpet has a Zacks Rank #4 and an Earnings ESP of -16.67%.
Stocks With Favorable Combination
Here are some companies you may want to consider as our model shows that they have the right combination of elements to post an earnings beat:
Darling Ingredients Inc. (DAR - Free Report) ) currently has an Earnings ESP of +10.09% and a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.
Medifast, Inc. (MED - Free Report) currently has an Earnings ESP of +7.27% and a Zacks Rank #2.
B&G Foods, Inc. (BGS - Free Report) has an Earnings ESP of +6.82% and a Zacks Rank #3, at present.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Freshpet, Inc. (FRPT - Free Report) — a renowned pet food products company — is likely to register top-line growth when it reports second-quarter 2021 results on Aug 2, after market close. The Zacks Consensus Estimate for revenues is pegged at $105.2 million, which indicates growth of 31.5% from the prior-year quarter’s reported figure.
The Zacks Consensus Estimate for second-quarter bottom line currently stands at a loss of 6 cents per share. The company incurred break-even earnings in the year-ago quarter. The consensus mark has remained stable in the past 30 days. The company incurred a loss in the past two quarters.
Key Aspects to Note
Freshpet’s top line during the second quarter is likely to have gained from strong product offerings backed by the company’s prudent innovation efforts. It has been ramping up distribution and trade inventory to cater to consumers’ needs for fresh and natural ingredients based pet food products. The company is gaining from improved shipments, consumption trends, retail availability and overall production levels.
Freshpet’s pet specialty channel is likely to have performed well in the second quarter, driven by expanded fridges across stores. These factors apart, the company’s sturdy e-commerce business and prudent efforts to boost international business are likely to have been upsides.
The company may have incurred higher fright costs in the to-be-reported quarter. Higher freight costs are a result of lower fill rates. Inflationary trends in beef and labor costs as well as higher production expenses are also likely to have dented the company’s bottom line.
What the Zacks Model Unveils
Our proven model does not conclusively predict an earnings beat for Freshpet this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Freshpet has a Zacks Rank #4 and an Earnings ESP of -16.67%.
Stocks With Favorable Combination
Here are some companies you may want to consider as our model shows that they have the right combination of elements to post an earnings beat:
Darling Ingredients Inc. (DAR - Free Report) ) currently has an Earnings ESP of +10.09% and a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.
Medifast, Inc. (MED - Free Report) currently has an Earnings ESP of +7.27% and a Zacks Rank #2.
B&G Foods, Inc. (BGS - Free Report) has an Earnings ESP of +6.82% and a Zacks Rank #3, at present.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on FRPT - FREE
Get the latest research report on DAR - FREE
Get the latest research report on BGS - FREE
Get the latest research report on MED - FREE